IDH2 and acute myeloid leukemia: Our ability to further investigate the prognostic value of IDH mutations and to appropriately study the correlation between IDH mutations and overall survival in AML patients was jeopardized by the fact that we have limited sample size (only one patient with IDH2 rs121913502 mutation) and failing to control confounding factors such as smoking.